{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T17:39:15Z","timestamp":1790185155137,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"University of Padjadjaran"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To evaluate the association between systemic biomarkers and the presence of diabetic macular edema (DME) with non-proliferative diabetic retinopathy (NPDR), and to assess the discriminative ability of these markers for identifying DME.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A cross-sectional study was conducted among 80 patients with type 2 diabetes mellitus and NPDR. Participants were categorized into DME and non-DME groups based on spectral-domain optical coherence tomography (OCT), with a central macular thickness\u2009\u2265\u2009300\u00a0\u03bcm defining DME. Hematological parameters were analyzed from complete blood counts. Statistical analysis was performed using SPSS 23.0.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 80 eyes (40 with DME and 40 without DME) were analyzed. Significant elevation of neutrophil counts was observed in the DME group (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.006). Similarly, NLR and SII values were higher in the DME group (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.075 and\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.048, respectively). The combined model of NLR, SII, and BMI showed moderate discriminatory ability (AUC 0.706,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.002). NPDR severity was significantly associated with DME in the univariate and multivariate analyses of the initial model (OR 3.023,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.049). This association lost statistical significance after adjustment for age and BMI. Systemic inflammatory markers (NLR, MLR, PLR, and SII) were not significantly associated with DME.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>SII and NLR demonstrated moderate discriminatory ability for identifying DME in patients with NPDR, particularly when integrated with the metabolic parameter BMI. These findings provide foundational evidence for the potential of using an accessible, cost-effective marker in diabetic retinal disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12886-026-04906-6","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T17:23:11Z","timestamp":1779902591000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Association of systemic inflammatory indices and body mass index with diabetic macular edema in non-proliferative diabetic retinopathy"],"prefix":"10.1186","volume":"26","author":[{"given":"Ohisa","family":"Harley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufilia Suci","family":"Amelia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsa","family":"Gustianty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanny N. M.","family":"Soetedjo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arief S.","family":"Kartasasmita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,27]]},"reference":[{"issue":"6","key":"4906_CR1","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1159\/000516614","volume":"244","author":"DAK Kuroiwa","year":"2021","unstructured":"Kuroiwa DAK, Malerbi FK, Regatieri CVS. New Insights in Resistant Diabetic Macular Edema. Ophthalmologica. 2021;244(6):485\u201394. https:\/\/doi.org\/10.1159\/000516614 PubMed PMID: 34023834.","journal-title":"Ophthalmologica"},{"issue":"5","key":"4906_CR2","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/S40265-017-0704-6","volume":"77","author":"SU Shah","year":"2017","unstructured":"Shah SU, Maturi RK. Therapeutic Options in Refractory Diabetic Macular Oedema. Drugs. 2017;77(5):481\u201392. https:\/\/doi.org\/10.1007\/S40265-017-0704-6 . PubMed PMID: 28197794.","journal-title":"Drugs"},{"issue":"12","key":"4906_CR3","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.4103\/ijo.IJO_1240_18","volume":"66","author":"DJ Browning","year":"2018","unstructured":"Browning DJ, Stewart MW, Lee C. Diabetic macular edema: Evidence-based management. Indian J Ophthalmol. 2018;66(12):1736\u201350. IJO.IJO_1240_18 PubMed PMID: 30451174.","journal-title":"Indian J Ophthalmol"},{"issue":"3","key":"4906_CR4","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1159\/000364955","volume":"232","author":"H Noma","year":"2014","unstructured":"Noma H, Mimura T, Yasuda K, Shimura M. Role of Inflammation in Diabetic Macular Edema. Ophthalmologica. 2014;232(3):127\u201335. https:\/\/doi.org\/10.1159\/000364955. PubMed PMID: 25342084.","journal-title":"Ophthalmologica"},{"key":"4906_CR5","doi-asserted-by":"publisher","DOI":"10.1080\/02713683.2025.2517300","author":"O Harley","year":"2025","unstructured":"Harley O, Amelia YS, Gustianty E, Soetedjo NNM, Kartasasmita AS. Retinal microglia: revealing new opportunities for identifying early biomarkers of diabetic retinopathy. Curr Eye Res. 2025. https:\/\/doi.org\/10.1080\/02713683.2025.2517300.","journal-title":"Curr Eye Res"},{"key":"4906_CR6","doi-asserted-by":"publisher","unstructured":"Zhang J, Zhang J, Zhang C, Zhang J, Gu L, Luo D et al. Diabetic macular edema: current understanding, molecular mechanisms and therapeutic implications. Cells. 2022;11(21):3362. https:\/\/doi.org\/10.3390\/CELLS11213362 PubMed PMID: 36359761.","DOI":"10.3390\/CELLS11213362"},{"key":"4906_CR7","doi-asserted-by":"publisher","unstructured":"Noma H, Yasuda K, Shimura M. Involvement of cytokines in the pathogenesis of diabetic macular edema. Int J Mol Sci. 2021;22(7):3427. https:\/\/doi.org\/10.3390\/IJMS22073427. PubMed PMID: 33810434.","DOI":"10.3390\/IJMS22073427"},{"key":"4906_CR8","doi-asserted-by":"publisher","unstructured":"Harley O, Amelia YS, Gustianty E, Soetedjo NNM, Kartasasmita AS. Exploring leukocyte differential count ratio profiles as inflammatory biomarkers in diabetic retinopathy: a systematic review and meta-analysis. BMC Ophthalmol. 2025;25(1). https:\/\/doi.org\/10.1186\/S12886-025-04075-Y . PubMed PMID: 40312699.","DOI":"10.1186\/S12886-025-04075-Y"},{"key":"4906_CR9","doi-asserted-by":"publisher","first-page":"1079217","DOI":"10.3389\/FENDO.2022.1079217","volume":"13","author":"Z Yang","year":"2022","unstructured":"Yang Z, Tan TE, Shao Y, Wong TY, Li X. Classification of diabetic retinopathy: Past, present and future. Front Endocrinol (Lausanne). 2022;13:1079217. https:\/\/doi.org\/10.3389\/FENDO.2022.1079217. \/FULL PubMed PMID: 36589807.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"4906_CR10","doi-asserted-by":"publisher","unstructured":"Yang S, Berdine G. The Receiver Operating Characteristic (ROC) curve. 2017;5(19):34. https:\/\/doi.org\/10.12746\/SWRCCC.V5I19.391","DOI":"10.12746\/SWRCCC.V5I19.391"},{"issue":"1","key":"4906_CR11","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1186\/S12886-025-04075-Y\/TABLES\/2","volume":"25","author":"O Harley","year":"2025","unstructured":"Harley O, Amelia YS, Gustianty E, Soetedjo NNM, Kartasasmita AS. Exploring leukocyte differential count ratio profiles as inflammatory biomarkers in diabetic retinopathy: a systematic review and meta-analysis. BMC Ophthalmol. 2025;25(1):265. https:\/\/doi.org\/10.1186\/S12886-025-04075-Y\/TABLES\/2 . PubMed PMID: 40312699.","journal-title":"BMC Ophthalmol"},{"key":"4906_CR12","doi-asserted-by":"publisher","unstructured":"Dascalu AM, Serban D, Tanasescu D, Vancea G, Cristea BM, Stana D, et al. The value of white cell inflammatory biomarkers as potential predictors for diabetic retinopathy in Type 2 Diabetes Mellitus (T2DM). Biomedicines. 2023;11(8). https:\/\/doi.org\/10.3390\/BIOMEDICINES11082106. PubMed PMID: 37626602.","DOI":"10.3390\/BIOMEDICINES11082106"},{"issue":"6","key":"4906_CR13","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.4103\/IJO.IJO_345_23","volume":"71","author":"CU Bhutia","year":"2023","unstructured":"Bhutia CU, Kaur P, Singh K, Kaur S. Evaluating peripheral blood inflammatory and metabolic biomarkers as predictors in diabetic retinopathy and diabetic macular edema. Indian J Ophthalmol. 2023;71(6):2521\u20135. IJO.IJO_345_23 PubMed PMID: 37322673.","journal-title":"Indian J Ophthalmol"},{"issue":"3","key":"4906_CR14","doi-asserted-by":"publisher","first-page":"e0173865","DOI":"10.1371\/journal.pone.0173865","volume":"12","author":"M Figueras-Roca","year":"2017","unstructured":"Figueras-Roca M, Molins B, Sala-Puigdollers A, Matas J, Vinagre I, R\u00edos J, et al. Peripheral blood metabolic and inflammatory factors as biomarkers to ocular findings in diabetic macular edema. PLoS ONE. 2017;12(3):e0173865. 10.1371. \/JOURNAL.PONE.0173865 PubMed PMID: 28328965.","journal-title":"PLoS ONE"},{"key":"4906_CR15","doi-asserted-by":"publisher","first-page":"1245199","DOI":"10.3389\/FENDO.2023.1245199\/BIBTEX","volume":"14","author":"Y Nie","year":"2023","unstructured":"Nie Y, Zhou H, Wang J, Kan H. Association between systemic immune-inflammation index and diabetes: a population-based study from the NHANES. Front Endocrinol (Lausanne). 2023;14:1245199. https:\/\/doi.org\/10.3389\/FENDO.2023.1245199\/BIBTEX.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"4906_CR16","doi-asserted-by":"publisher","first-page":"219","DOI":"10.5336\/OPHTHAL.2024-103341","volume":"33","author":"L Dogan","year":"2024","unstructured":"Dogan L, Ozer \u00d6, Guclu E. The Effect of Systemic Inflammatory Biomarkers and Dyslipidemia on the Prognosis of Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus: Retrospective Research. Turkiye Klinikleri J Ophthalmol. 2024;33(4):219\u201328. https:\/\/doi.org\/10.5336\/OPHTHAL.2024-103341.","journal-title":"Turkiye Klinikleri J Ophthalmol"},{"key":"4906_CR17","doi-asserted-by":"publisher","unstructured":"Zhou T, Hu Z, Yang S, Sun L, Yu Z, Wang G. Role of adaptive and innate immunity in type 2 diabetes mellitus. J Diabetes Res. 2018;2018. https:\/\/doi.org\/10.1155\/2018\/7457269 PubMed PMID: 30533447.","DOI":"10.1155\/2018\/7457269"},{"key":"4906_CR18","doi-asserted-by":"publisher","unstructured":"Xia C, Rao X, Zhong J. Role of T lymphocytes in type 2 diabetes and diabetes-associated inflammation. J Diabetes Res. 2017;2017. https:\/\/doi.org\/10.1155\/2017\/6494795. PubMed PMID: 28251163.","DOI":"10.1155\/2017\/6494795"},{"issue":"4","key":"4906_CR19","doi-asserted-by":"publisher","first-page":"598","DOI":"10.4239\/WJD.V6","volume":"6","author":"I Hameed","year":"2015","unstructured":"Hameed I, Masoodi SR, Mir SA, Nabi M, Ghazanfar K, Ganai BA. Type 2 diabetes mellitus: From a metabolic disorder to an inflammatory condition. World J Diabetes. 2015;6(4):598. https:\/\/doi.org\/10.4239\/WJD.V6. I4.598 PubMed PMID: 25987957.","journal-title":"World J Diabetes"},{"key":"4906_CR20","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/J.CCA","volume":"507","author":"J Chen","year":"2020","unstructured":"Chen J, Tan W. Platelet activation and immune response in diabetic microangiopathy. Clin Chim Acta. 2020;507:242\u20137. https:\/\/doi.org\/10.1016\/J.CCA. .2020.04.042 PubMed PMID: 32376322.","journal-title":"Clin Chim Acta"},{"key":"4906_CR21","doi-asserted-by":"publisher","unstructured":"Ogura S, Kurata K, Hattori Y, Takase H, Ishiguro-Oonuma T, Hwang Y, et al. Sustained inflammation after pericyte depletion induces irreversible blood-retina barrier breakdown. JCI Insight. 2017;2(3). https:\/\/doi.org\/10.1172\/.JCI.INSIGHT.90905. PubMed PMID: 28194443.","DOI":"10.1172\/.JCI.INSIGHT.90905"},{"key":"4906_CR22","doi-asserted-by":"publisher","unstructured":"Huang H, Gandhi JK, Zhong X, Wei Y, Gong J, Duh EJ, et al. TNF\u03b1 is required for late BRB breakdown in diabetic retinopathy, and its inhibition prevents leukostasis and protects vessels and neurons from apoptosis. Invest Ophthalmol Vis Sci. 2011;52(3):1336\u201344. https:\/\/doi.org\/10.1167\/IOVS.10-5768\/-\/DCSUPPLEMENTAL PubMed PMID: 21212173.","DOI":"10.1167\/IOVS.10-5768\/-\/DCSUPPLEMENTAL"},{"key":"4906_CR23","doi-asserted-by":"publisher","first-page":"3827","DOI":"10.2147\/DMSO.S437580","volume":"16","author":"S Wang","year":"2023","unstructured":"Wang S, Pan X, Jia B, Chen S. Exploring the Correlation Between the Systemic Immune Inflammation Index (SII), Systemic Inflammatory Response Index (SIRI), and Type 2 Diabetic Retinopathy. Diabetes Metabolic Syndrome Obes. 2023;16:3827\u201336. https:\/\/doi.org\/10.2147\/DMSO.S437580.","journal-title":"Diabetes Metabolic Syndrome Obes"},{"issue":"4","key":"4906_CR24","doi-asserted-by":"publisher","first-page":"299","DOI":"10.5935\/0004-2749.20200051","volume":"83","author":"C Ilhan","year":"2020","unstructured":"Ilhan C, Citirik M, Uzel MM, Kiziltoprak H, Tekin K. The usefulness of systemic inflammatory markers as diagnostic indicators of the pathogenesis of diabetic macular edema. Arq Bras Oftalmol. 2020;83(4):299\u2013304. https:\/\/doi.org\/10.5935\/0004-2749.20200051 . PubMed PMID: 32756784.","journal-title":"Arq Bras Oftalmol"},{"key":"4906_CR25","doi-asserted-by":"publisher","unstructured":"Yumnamcha T, Guerra M, Singh LP, Ibrahim AS. Metabolic dysregulation and neurovascular dysfunction in diabetic retinopathy. Antioxidants. 2020;9(12):1\u201322. https:\/\/doi.org\/10.3390\/ANTIOX9121244","DOI":"10.3390\/ANTIOX9121244"},{"issue":"5","key":"4906_CR26","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/J.EXER","volume":"90","author":"RA Kowluru","year":"2010","unstructured":"Kowluru RA, Zhong Q, Kanwar M. Metabolic Memory and Diabetic retinopathy: Role of Inflammatory Mediators in Retinal Pericytes. Exp Eye Res. 2010;90(5):617. https:\/\/doi.org\/10.1016\/J.EXER. .2010.02.006 PubMed PMID: 20170650.","journal-title":"Exp Eye Res"},{"issue":"4","key":"4906_CR27","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.3390\/nu5041218","volume":"5","author":"B Klop","year":"2013","unstructured":"Klop B, Elte JWF, Cabezas MC. Dyslipidemia in obesity: mechanisms and potential targets. Nutrients. 2013;5(4):1218\u201340. https:\/\/doi.org\/10.3390\/NU5041218 PubMed PMID: 23584084.","journal-title":"Nutrients"},{"issue":"8","key":"4906_CR28","doi-asserted-by":"publisher","first-page":"10009","DOI":"10.3390\/ijerph120810009","volume":"12","author":"S Yue","year":"2015","unstructured":"Yue S, Zhang J, Wu J, Teng W, Liu L, Chen L. Use of the Monocyte-to-Lymphocyte Ratio to Predict Diabetic Retinopathy. Int J Environ Res Public Health. 2015;12(8):10009\u201319. https:\/\/doi.org\/10.3390\/IJERPH120810009 PubMed PMID: 26308022.","journal-title":"Int J Environ Res Public Health"},{"key":"4906_CR29","unstructured":"Sari DA, Delfi, Virgayanti V, Sari MD. Evaluation of neutrophil-to-lymphocyte ratio, monocyte-to-lymphocyte ratio and platelet-to-lymphocyte ratio as predictor factors on diabetic retinopathy. Eur Mod Stud J [Internet]. 2021 Nov 22 [cited 2024 Dec 8];5(5):168\u2013176. Available from: https:\/\/journal-ems.com\/index.php\/emsj\/article\/view\/369"},{"key":"4906_CR30","doi-asserted-by":"publisher","unstructured":"Dascalu AM, Georgescu A, Costea AC, Tribus L, El Youssoufi A, Serban D, et al. Association between Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte Ratio (PLR) with diabetic retinopathy in type 2 diabetic patients. Cureus. 2023;15(11):e48628. https:\/\/doi.org\/10.7759\/cureus.48581. PubMed PMID: 38090430.","DOI":"10.7759\/cureus.48581"},{"issue":"1","key":"4906_CR31","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/S40942-025-00794-Y\/FIGURES\/3","volume":"12","author":"O Harley","year":"2026","unstructured":"Harley O, Amelia YS, Gustianty E, Soetedjo NNM, Kartasasmita AS. Systemic\u2013retinal inflammatory crosstalk in diabetic macular edema: correlation between hematologic indices and macular OCT-features. Int J Retina Vitreous. 2026;12(1):32. https:\/\/doi.org\/10.1186\/S40942-025-00794-Y\/FIGURES\/3.","journal-title":"Int J Retina Vitreous"},{"issue":"6","key":"4906_CR32","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1007\/s40123-022-00576-x","volume":"11","author":"J Zhou","year":"2022","unstructured":"Zhou J, Song S, Zhang Y, Jin K, Ye J. OCT-Based Biomarkers are Associated with Systemic Inflammation in Patients with Treatment-Na\u00efve Diabetic Macular Edema. Ophthalmol Ther. 2022;11(6):2153\u201367. 00576-X PubMed PMID: 36166152.","journal-title":"Ophthalmol Ther"},{"issue":"1","key":"4906_CR33","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1159\/000535199","volume":"67","author":"C Yanxia","year":"2024","unstructured":"Yanxia C, Xiongyi Y, Min F, Xiaoyun K. Optical Coherence Tomography-Based Grading of Diabetic Macular Edema Is Associated with Systemic Inflammatory Indices and Imaging Biomarkers. Ophthalmic Res. 2024;67(1):96\u2013106. https:\/\/doi.org\/10.1159\/000535199 PubMed PMID: 38211574.","journal-title":"Ophthalmic Res"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-026-04906-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-026-04906-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-026-04906-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T07:47:30Z","timestamp":1779954450000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12886-026-04906-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,27]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4906"],"URL":"https:\/\/doi.org\/10.1186\/s12886-026-04906-6","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,27]]},"assertion":[{"value":"22 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of Universitas Padjadjaran (No. 85\/UN6.KEP\/EC\/2025). Written informed consent was obtained from all participants prior to enrollment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"294"}}